Adage Capital Partners Gp, L.L.C. Ideaya Biosciences, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$59.7 Billion
Q3 2025

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,900,094 shares of IDYA stock, worth $93.2 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

2,900,094

Previous 1,238,094 134.24%

Holding current value

$93.2 Million

Previous $26 Million 203.22%

% of portfolio

0.13%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$21.12 - $27.21 $35.1 Million - $45.2 Million	1,662,000 Added 134.24%	2,900,094 $78.9 Million
Q2 2025 Aug 14, 2025	BUY	$14.5 - $22.63 $725,000 - $1.13 Million	50,000 Added 4.21%	1,238,094 $26 Million
Q1 2025 May 15, 2025	SELL	$16.38 - $26.0 $196,560 - $312,000	-12,000 Reduced 1.0%	1,188,094 $19.5 Million
Q4 2024 Feb 14, 2025	BUY	$24.79 - $31.98 $5.45 Million - $7.04 Million	220,000 Added 22.45%	1,200,094 $30.8 Million
Q3 2024 Nov 14, 2024	SELL	$30.37 - $43.05 $33 Million - $46.7 Million	-1,085,000 Reduced 52.54%	980,094 $31 Million
Q2 2024 Aug 14, 2024	SELL	$34.37 - $43.46 $13.8 Million - $17.5 Million	-402,013 Reduced 16.29%	2,065,094 $72.5 Million
Q1 2024 May 15, 2024	SELL	$34.2 - $47.13 $15.7 Million - $21.6 Million	-457,987 Reduced 15.66%	2,467,107 $108 Million
Q4 2023 Feb 14, 2024	BUY	$24.59 - $35.83 $15.7 Million - $22.9 Million	638,133 Added 27.9%	2,925,094 $104 Million
Q3 2023 Nov 14, 2023	SELL	$21.07 - $29.77 $6.07 Million - $8.58 Million	-288,149 Reduced 11.19%	2,286,961 $61.7 Million
Q2 2023 Aug 14, 2023	SELL	$13.33 - $25.53 $1.35 Million - $2.59 Million	-101,449 Reduced 3.79%	2,575,110 $60.5 Million
Q1 2023 May 15, 2023	BUY	$13.49 - $18.72 $6.41 Million - $8.89 Million	475,000 Added 21.58%	2,676,559 $36.7 Million
Q4 2022 Feb 14, 2023	BUY	$14.47 - $18.17 $5.09 Million - $6.39 Million	351,465 Added 19.0%	2,201,559 $40 Million
Q3 2022 Nov 14, 2022	BUY	$9.24 - $15.79 $16.1 Million - $27.6 Million	1,745,693 Added 1672.1%	1,850,094 $27.6 Million
Q2 2022 Aug 15, 2022	SELL	$8.28 - $13.88 $736,092 - $1.23 Million	-88,900 Reduced 45.99%	104,401 $1.44 Million
Q1 2022 May 16, 2022	SELL	$11.18 - $24.02 $559,469 - $1.2 Million	-50,042 Reduced 20.56%	193,301 $2.16 Million
Q4 2021 Feb 14, 2022	SELL	$20.95 - $26.88 $139,464 - $178,940	-6,657 Reduced 2.66%	243,343 $5.75 Million
Q3 2021 Nov 15, 2021	SELL	$17.26 - $27.08 $2.73 Million - $4.28 Million	-157,899 Reduced 38.71%	250,000 $6.37 Million
Q2 2021 Aug 16, 2021	SELL	$17.76 - $24.83 $1.78 Million - $2.48 Million	-100,000 Reduced 19.69%	407,899 $8.56 Million
Q1 2021 May 17, 2021	BUY	$13.48 - $23.77 $6.85 Million - $12.1 Million	507,899 New	507,899 $11.9 Million

Others Institutions Holding IDYA

# of Institutions

240

Shares Held

82.1M

Call Options Held

509K

Put Options Held

103K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.54B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Ideaya Biosciences, Inc. Transaction History